<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND METHODS: <z:chebi fb="0" ids="3962">Curcumin</z:chebi> has extraordinary anticancer properties but has limited use due to its insolubility in water and instability, which leads to low systemic bioavailability </plain></SENT>
<SENT sid="1" pm="."><plain>We have developed a novel nanoparticulate formulation of <z:chebi fb="0" ids="3962">curcumin</z:chebi> encapsulated in <z:chebi fb="0" ids="28842">stearic acid</z:chebi>-g-<z:chebi fb="0" ids="16261">chitosan</z:chebi> <z:chebi fb="2" ids="50699">oligosaccharide</z:chebi> (<z:chebi fb="97" ids="48272">CSO</z:chebi>-SA) polymeric micelles to overcome these hurdles </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The synthesized <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA <z:chebi fb="5" ids="53310">copolymer</z:chebi> was able to self-assemble to form nanoscale micelles in aqueous medium </plain></SENT>
<SENT sid="3" pm="."><plain>The mean diameter of the <z:chebi fb="0" ids="3962">curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles was 114.7 nm and their mean surface potential was 18.5 mV </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles showed excellent internalization ability that increased <z:chebi fb="0" ids="3962">curcumin</z:chebi> accumulation in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles also had potent antiproliferative effects on primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro, resulting in about 6-fold greater inhibition compared with cells treated with a solution containing an equivalent concentration of free <z:chebi fb="0" ids="3962">curcumin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Intravenous administration of <z:chebi fb="0" ids="3962">curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles marginally suppressed <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> but did not increase cytotoxicity to mice, as confirmed by no change in body weight </plain></SENT>
<SENT sid="7" pm="."><plain>Most importantly, <z:chebi fb="0" ids="3962">curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles were effective for inhibiting subpopulations of CD44(+)/CD24(+) cells (putative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> stem cell markers) both in vitro and in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The present study identifies an effective and safe means of using <z:chebi fb="0" ids="3962">curcumin</z:chebi>-loaded <z:chebi fb="97" ids="48272">CSO</z:chebi>-SA micelles for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
</text></document>